Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes?

Ann Oncol. 2021 Jun;32(6):814-816. doi: 10.1016/j.annonc.2021.02.022. Epub 2021 Mar 5.

¹ Immunotherapy of Human Tumors Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: elena.daveri@istitutotumori.mi.it.
² Biomarkers Unit, Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³ Immunotherapy of Human Tumors Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁴ School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.
⁵ Medical Oncology Department 1, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.
⁶ Immunotherapy of Human Tumors Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: licia.rivoltini@istitutotumori.mi.it.

No abstract available

Publication types